Search results
Dalal Street Week Ahead: Q1 earnings, US inflation, Powell testimony, FII activity top 10 key...
CNBC Awaaz· 20 hours agoGoing ahead, analysts expect the trend to largely remain positive, however, bouts of volatility can...
Lava banks on product quality, after-sales to boost smartphone market share
Financial Express· 2 days agoLava looks to raise Rs 500 crore via private equity before IPO.
Emcure Pharmaceuticals IPO booked over 13 times so far on Day 3. Check GMP and other details - The...
The Economic Times· 3 days agoThe initial public offer (IPO) of Emcure Pharmaceuticals was booked over 13 times so far on the third day of the bidding process. Ahead of the issue opening, the company raised ...
Emcure Pharma IPO: GMP surges on last day; issue subscribed 24 times so far - CNBC TV18
CNBC TV18· 3 days agoThe initial share sale of Emcure Pharmaceuticals was off to a strong start on the last day of the...
Emcure Pharmaceuticals IPO subscribed 4.98 times on Day 2 | India Infoline
India Infoline· 3 days agoThe IPO will be open till July 5 and will include ₹800 Crore in fresh equity offering as well as an OFS of 1.14 crore shares by promoters and other shareholders. Shark < ...
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 4 days agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital,...
Emcure Pharmaceuticals IPO Day 2: From key risks to financials, here are 10 things to know from RHP...
Livemint· 4 days agoEmcure Pharmaceuticals IPO saw positive investor response with overwhelming demand, offering new...
Meet Namita Thapar, Shark Tank Judge Who is Raking in Nearly Rs 128 Crore via Emcure Pharma IPO -...
News18· 4 days agoNamita Thapar is a remarkably successful businesswoman who is also an investor on Shark Tank India...
Emcure Pharma IPO: Issue fully subscribed on day 1; check subscription status, GMP and other details...
Livemint· 5 days agoBefore the issue opened, the company secured ₹582 crore from anchor investors. Notable participants...
Emcure Pharmaceuticals IPO: 10 key risks investors should consider before subscribing to the...
Livemint· 5 days agoEmcure Pharmaceuticals IPO sails through first day of bidding smoothly led by non institutional and...